Actively Recruiting
Led by University Hospital, Geneva · Updated on 2021-01-13
6000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating genetic factors that may influence complications in children and adolescents who have had cancer in Switzerland. This study aims to find genetic variants linked to both short- and long-term complications, including organ dysfunctions and secondary cancers, by combining genetic data with clinical information collected across the country. The project seeks to enhance understanding of how genetics affect treatment outcomes and complications to help personalize care. Participants provide biological samples such as saliva, buccal swabs, or blood for genetic testing, along with clinical data obtained through medical chart reviews. The study uses germline DNA samples stored in a biobank and links this information with detailed clinical records. This observational study collects data at enrollment and continues gathering follow-up information for approximately 10 years. During the study, researchers review medical records and cancer registry information to assess complications, including organ dysfunction and second primary tumors. Genetic sequencing is performed at enrollment to identify potential risk markers. The study monitors demographic and clinical factors that may influence outcomes, with ongoing data collection until the last follow-up or death. The total participation time can extend over many years, supporting long-term insights into childhood cancer complications.
CONDITIONS
Genetic Risks for Childhood Cancer Complications in Switzerland
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At enrollment
Participants provide biospecimens such as saliva, buccal swabs, or blood for genetic analysis and clinical data are collected from medical charts.
1 visit (in-person)
Duration - Up to approximately 10 years
Participants are followed with ongoing collection of clinical data and monitoring of complications after childhood cancer over time.
Visits as per medical record updates and registry data collection
Total: 1 location
1
University Hospital of Geneva
Geneva, Switzerland, 1211
Actively Recruiting
M
Marc Ansari, Prof
N
Nicolas Waespe, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nicolas Waespe, Sven Strebel, Tiago Nava...
https://pubmed.ncbi.nlm.nih.gov/35074812Nicolas Waespe, Sven Strebel, Denis Marino...
https://pubmed.ncbi.nlm.nih.gov/34717553